Global Travelers Vaccines Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Travelers Vaccines Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Page: 92

Published Date: 02 Jan 2024

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

  • sp_icon1 sp_icon1_b Description
  • sp_icon2 sp_icon2_b Table of Contents
  • sp_icon3 sp_icon3_b Table of Figures
  • sp_icon4 sp_icon4_b Research Methodology
  • sp_icon1 sp_icon1_b Companies Mentioned
  • sp_icon1 sp_icon1_b Related Reports
  • sp_icon1 sp_icon1_b Product Tags
btl

Description

According to our (Global Info Research) latest study, the global Travelers Vaccines market size was valued at USD 3460.7 million in 2023 and is forecast to a readjusted size of USD 6095 million by 2030 with a CAGR of 8.4% during review period.

A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as foreign, destroy it, and "remember" it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.

Travelers are at increased risk for several infections, including familiar infections such as measles that are widely distributed but more common in developing countries. Travelers Vaccines can markedly decrease the risk for many of these infections and are an important part of pretravel preparation.

In this report, the travelers vaccines mainly covers vaccine for hepatitis A, hepatitis B, rabies, typhoid fever, yellow fever, Japanese encephalitis, meningococcal meningitis, cholera, etc.

Merck, GlaxoSmithKline and Sanofi Pasteur are the main manufacturers in the vaccine market, with a market share of more than 60% and a high degree of market concentration. North America and Europe are the main production regions, with market share of more than 40% and 30%.

The Global Info Research report includes an overview of the development of the Travelers Vaccines industry chain, the market status of Tourists (Meningococcal Vaccine, Japanese Encephalitis Vaccine), Students (Meningococcal Vaccine, Japanese Encephalitis Vaccine), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Travelers Vaccines.

Regionally, the report analyzes the Travelers Vaccines markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Travelers Vaccines market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Travelers Vaccines market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Travelers Vaccines industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Doses), revenue generated, and market share of different by Type (e.g., Meningococcal Vaccine, Japanese Encephalitis Vaccine).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Travelers Vaccines market.

Regional Analysis: The report involves examining the Travelers Vaccines market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Travelers Vaccines market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Travelers Vaccines:
Company Analysis: Report covers individual Travelers Vaccines manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Travelers Vaccines This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by End Users (Tourists, Students).

Technology Analysis: Report covers specific technologies relevant to Travelers Vaccines. It assesses the current state, advancements, and potential future developments in Travelers Vaccines areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Travelers Vaccines market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Travelers Vaccines market is split by Type and by End Users. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by End Users in terms of volume and value.

Market segment by Type
Meningococcal Vaccine
Japanese Encephalitis Vaccine
Yellow Fever Vaccine
Hepatitis Vaccine
Cholera Vaccine
Other

Market segment by End Users
Tourists
Students
Workers
Others

Major players covered
GlaxoSmithKline
Sanofi Pasteur
Merck
Pfizer
CNBG
Sanofi Pasteur MSD
Serum Institute of India
Biokangtai

Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Travelers Vaccines product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Travelers Vaccines, with price, sales, revenue and global market share of Travelers Vaccines from 2019 to 2024.
Chapter 3, the Travelers Vaccines competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Travelers Vaccines breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and end users, with sales market share and growth rate by type, end users, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Travelers Vaccines market forecast, by regions, type and end users, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Travelers Vaccines.
Chapter 14 and 15, to describe Travelers Vaccines sales channel, distributors, customers, research findings and conclusion.
btl

Table of Contents

1 Market Overview
1.1 Product Overview and Scope of Travelers Vaccines
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Travelers Vaccines Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Meningococcal Vaccine
1.3.3 Japanese Encephalitis Vaccine
1.3.4 Yellow Fever Vaccine
1.3.5 Hepatitis Vaccine
1.3.6 Cholera Vaccine
1.3.7 Other
1.4 Market Analysis by End Users
1.4.1 Overview: Global Travelers Vaccines Consumption Value by End Users: 2019 Versus 2023 Versus 2030
1.4.2 Tourists
1.4.3 Students
1.4.4 Workers
1.4.5 Others
1.5 Global Travelers Vaccines Market Size & Forecast
1.5.1 Global Travelers Vaccines Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Travelers Vaccines Sales Quantity (2019-2030)
1.5.3 Global Travelers Vaccines Average Price (2019-2030)

2 Manufacturers Profiles
2.1 GlaxoSmithKline
2.1.1 GlaxoSmithKline Details
2.1.2 GlaxoSmithKline Major Business
2.1.3 GlaxoSmithKline Travelers Vaccines Product and Services
2.1.4 GlaxoSmithKline Travelers Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 GlaxoSmithKline Recent Developments/Updates
2.2 Sanofi Pasteur
2.2.1 Sanofi Pasteur Details
2.2.2 Sanofi Pasteur Major Business
2.2.3 Sanofi Pasteur Travelers Vaccines Product and Services
2.2.4 Sanofi Pasteur Travelers Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Sanofi Pasteur Recent Developments/Updates
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business
2.3.3 Merck Travelers Vaccines Product and Services
2.3.4 Merck Travelers Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Merck Recent Developments/Updates
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business
2.4.3 Pfizer Travelers Vaccines Product and Services
2.4.4 Pfizer Travelers Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Pfizer Recent Developments/Updates
2.5 CNBG
2.5.1 CNBG Details
2.5.2 CNBG Major Business
2.5.3 CNBG Travelers Vaccines Product and Services
2.5.4 CNBG Travelers Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 CNBG Recent Developments/Updates
2.6 Sanofi Pasteur MSD
2.6.1 Sanofi Pasteur MSD Details
2.6.2 Sanofi Pasteur MSD Major Business
2.6.3 Sanofi Pasteur MSD Travelers Vaccines Product and Services
2.6.4 Sanofi Pasteur MSD Travelers Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Sanofi Pasteur MSD Recent Developments/Updates
2.7 Serum Institute of India
2.7.1 Serum Institute of India Details
2.7.2 Serum Institute of India Major Business
2.7.3 Serum Institute of India Travelers Vaccines Product and Services
2.7.4 Serum Institute of India Travelers Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Serum Institute of India Recent Developments/Updates
2.8 Biokangtai
2.8.1 Biokangtai Details
2.8.2 Biokangtai Major Business
2.8.3 Biokangtai Travelers Vaccines Product and Services
2.8.4 Biokangtai Travelers Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Biokangtai Recent Developments/Updates

3 Competitive Environment: Travelers Vaccines by Manufacturer
3.1 Global Travelers Vaccines Sales Quantity by Manufacturer (2019-2024)
3.2 Global Travelers Vaccines Revenue by Manufacturer (2019-2024)
3.3 Global Travelers Vaccines Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Travelers Vaccines by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Travelers Vaccines Manufacturer Market Share in 2023
3.4.2 Top 6 Travelers Vaccines Manufacturer Market Share in 2023
3.5 Travelers Vaccines Market: Overall Company Footprint Analysis
3.5.1 Travelers Vaccines Market: Region Footprint
3.5.2 Travelers Vaccines Market: Company Product Type Footprint
3.5.3 Travelers Vaccines Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
4.1 Global Travelers Vaccines Market Size by Region
4.1.1 Global Travelers Vaccines Sales Quantity by Region (2019-2030)
4.1.2 Global Travelers Vaccines Consumption Value by Region (2019-2030)
4.1.3 Global Travelers Vaccines Average Price by Region (2019-2030)
4.2 North America Travelers Vaccines Consumption Value (2019-2030)
4.3 Europe Travelers Vaccines Consumption Value (2019-2030)
4.4 Asia-Pacific Travelers Vaccines Consumption Value (2019-2030)
4.5 South America Travelers Vaccines Consumption Value (2019-2030)
4.6 Middle East and Africa Travelers Vaccines Consumption Value (2019-2030)

5 Market Segment by Type
5.1 Global Travelers Vaccines Sales Quantity by Type (2019-2030)
5.2 Global Travelers Vaccines Consumption Value by Type (2019-2030)
5.3 Global Travelers Vaccines Average Price by Type (2019-2030)

6 Market Segment by End Users
6.1 Global Travelers Vaccines Sales Quantity by End Users (2019-2030)
6.2 Global Travelers Vaccines Consumption Value by End Users (2019-2030)
6.3 Global Travelers Vaccines Average Price by End Users (2019-2030)

7 North America
7.1 North America Travelers Vaccines Sales Quantity by Type (2019-2030)
7.2 North America Travelers Vaccines Sales Quantity by End Users (2019-2030)
7.3 North America Travelers Vaccines Market Size by Country
7.3.1 North America Travelers Vaccines Sales Quantity by Country (2019-2030)
7.3.2 North America Travelers Vaccines Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe
8.1 Europe Travelers Vaccines Sales Quantity by Type (2019-2030)
8.2 Europe Travelers Vaccines Sales Quantity by End Users (2019-2030)
8.3 Europe Travelers Vaccines Market Size by Country
8.3.1 Europe Travelers Vaccines Sales Quantity by Country (2019-2030)
8.3.2 Europe Travelers Vaccines Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific
9.1 Asia-Pacific Travelers Vaccines Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Travelers Vaccines Sales Quantity by End Users (2019-2030)
9.3 Asia-Pacific Travelers Vaccines Market Size by Region
9.3.1 Asia-Pacific Travelers Vaccines Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Travelers Vaccines Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America
10.1 South America Travelers Vaccines Sales Quantity by Type (2019-2030)
10.2 South America Travelers Vaccines Sales Quantity by End Users (2019-2030)
10.3 South America Travelers Vaccines Market Size by Country
10.3.1 South America Travelers Vaccines Sales Quantity by Country (2019-2030)
10.3.2 South America Travelers Vaccines Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa
11.1 Middle East & Africa Travelers Vaccines Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Travelers Vaccines Sales Quantity by End Users (2019-2030)
11.3 Middle East & Africa Travelers Vaccines Market Size by Country
11.3.1 Middle East & Africa Travelers Vaccines Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Travelers Vaccines Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics
12.1 Travelers Vaccines Market Drivers
12.2 Travelers Vaccines Market Restraints
12.3 Travelers Vaccines Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain
13.1 Raw Material of Travelers Vaccines and Key Manufacturers
13.2 Manufacturing Costs Percentage of Travelers Vaccines
13.3 Travelers Vaccines Production Process
13.4 Travelers Vaccines Industrial Chain

14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Travelers Vaccines Typical Distributors
14.3 Travelers Vaccines Typical Customers

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. Global Travelers Vaccines Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Travelers Vaccines Consumption Value by End Users, (USD Million), 2019 & 2023 & 2030
Table 3. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 4. GlaxoSmithKline Major Business
Table 5. GlaxoSmithKline Travelers Vaccines Product and Services
Table 6. GlaxoSmithKline Travelers Vaccines Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. GlaxoSmithKline Recent Developments/Updates
Table 8. Sanofi Pasteur Basic Information, Manufacturing Base and Competitors
Table 9. Sanofi Pasteur Major Business
Table 10. Sanofi Pasteur Travelers Vaccines Product and Services
Table 11. Sanofi Pasteur Travelers Vaccines Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Sanofi Pasteur Recent Developments/Updates
Table 13. Merck Basic Information, Manufacturing Base and Competitors
Table 14. Merck Major Business
Table 15. Merck Travelers Vaccines Product and Services
Table 16. Merck Travelers Vaccines Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Merck Recent Developments/Updates
Table 18. Pfizer Basic Information, Manufacturing Base and Competitors
Table 19. Pfizer Major Business
Table 20. Pfizer Travelers Vaccines Product and Services
Table 21. Pfizer Travelers Vaccines Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Pfizer Recent Developments/Updates
Table 23. CNBG Basic Information, Manufacturing Base and Competitors
Table 24. CNBG Major Business
Table 25. CNBG Travelers Vaccines Product and Services
Table 26. CNBG Travelers Vaccines Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. CNBG Recent Developments/Updates
Table 28. Sanofi Pasteur MSD Basic Information, Manufacturing Base and Competitors
Table 29. Sanofi Pasteur MSD Major Business
Table 30. Sanofi Pasteur MSD Travelers Vaccines Product and Services
Table 31. Sanofi Pasteur MSD Travelers Vaccines Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Sanofi Pasteur MSD Recent Developments/Updates
Table 33. Serum Institute of India Basic Information, Manufacturing Base and Competitors
Table 34. Serum Institute of India Major Business
Table 35. Serum Institute of India Travelers Vaccines Product and Services
Table 36. Serum Institute of India Travelers Vaccines Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Serum Institute of India Recent Developments/Updates
Table 38. Biokangtai Basic Information, Manufacturing Base and Competitors
Table 39. Biokangtai Major Business
Table 40. Biokangtai Travelers Vaccines Product and Services
Table 41. Biokangtai Travelers Vaccines Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Biokangtai Recent Developments/Updates
Table 43. Global Travelers Vaccines Sales Quantity by Manufacturer (2019-2024) & (K Doses)
Table 44. Global Travelers Vaccines Revenue by Manufacturer (2019-2024) & (USD Million)
Table 45. Global Travelers Vaccines Average Price by Manufacturer (2019-2024) & (USD/Dose)
Table 46. Market Position of Manufacturers in Travelers Vaccines, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 47. Head Office and Travelers Vaccines Production Site of Key Manufacturer
Table 48. Travelers Vaccines Market: Company Product Type Footprint
Table 49. Travelers Vaccines Market: Company Product Application Footprint
Table 50. Travelers Vaccines New Market Entrants and Barriers to Market Entry
Table 51. Travelers Vaccines Mergers, Acquisition, Agreements, and Collaborations
Table 52. Global Travelers Vaccines Sales Quantity by Region (2019-2024) & (K Doses)
Table 53. Global Travelers Vaccines Sales Quantity by Region (2025-2030) & (K Doses)
Table 54. Global Travelers Vaccines Consumption Value by Region (2019-2024) & (USD Million)
Table 55. Global Travelers Vaccines Consumption Value by Region (2025-2030) & (USD Million)
Table 56. Global Travelers Vaccines Average Price by Region (2019-2024) & (USD/Dose)
Table 57. Global Travelers Vaccines Average Price by Region (2025-2030) & (USD/Dose)
Table 58. Global Travelers Vaccines Sales Quantity by Type (2019-2024) & (K Doses)
Table 59. Global Travelers Vaccines Sales Quantity by Type (2025-2030) & (K Doses)
Table 60. Global Travelers Vaccines Consumption Value by Type (2019-2024) & (USD Million)
Table 61. Global Travelers Vaccines Consumption Value by Type (2025-2030) & (USD Million)
Table 62. Global Travelers Vaccines Average Price by Type (2019-2024) & (USD/Dose)
Table 63. Global Travelers Vaccines Average Price by Type (2025-2030) & (USD/Dose)
Table 64. Global Travelers Vaccines Sales Quantity by End Users (2019-2024) & (K Doses)
Table 65. Global Travelers Vaccines Sales Quantity by End Users (2025-2030) & (K Doses)
Table 66. Global Travelers Vaccines Consumption Value by End Users (2019-2024) & (USD Million)
Table 67. Global Travelers Vaccines Consumption Value by End Users (2025-2030) & (USD Million)
Table 68. Global Travelers Vaccines Average Price by End Users (2019-2024) & (USD/Dose)
Table 69. Global Travelers Vaccines Average Price by End Users (2025-2030) & (USD/Dose)
Table 70. North America Travelers Vaccines Sales Quantity by Type (2019-2024) & (K Doses)
Table 71. North America Travelers Vaccines Sales Quantity by Type (2025-2030) & (K Doses)
Table 72. North America Travelers Vaccines Sales Quantity by End Users (2019-2024) & (K Doses)
Table 73. North America Travelers Vaccines Sales Quantity by End Users (2025-2030) & (K Doses)
Table 74. North America Travelers Vaccines Sales Quantity by Country (2019-2024) & (K Doses)
Table 75. North America Travelers Vaccines Sales Quantity by Country (2025-2030) & (K Doses)
Table 76. North America Travelers Vaccines Consumption Value by Country (2019-2024) & (USD Million)
Table 77. North America Travelers Vaccines Consumption Value by Country (2025-2030) & (USD Million)
Table 78. Europe Travelers Vaccines Sales Quantity by Type (2019-2024) & (K Doses)
Table 79. Europe Travelers Vaccines Sales Quantity by Type (2025-2030) & (K Doses)
Table 80. Europe Travelers Vaccines Sales Quantity by End Users (2019-2024) & (K Doses)
Table 81. Europe Travelers Vaccines Sales Quantity by End Users (2025-2030) & (K Doses)
Table 82. Europe Travelers Vaccines Sales Quantity by Country (2019-2024) & (K Doses)
Table 83. Europe Travelers Vaccines Sales Quantity by Country (2025-2030) & (K Doses)
Table 84. Europe Travelers Vaccines Consumption Value by Country (2019-2024) & (USD Million)
Table 85. Europe Travelers Vaccines Consumption Value by Country (2025-2030) & (USD Million)
Table 86. Asia-Pacific Travelers Vaccines Sales Quantity by Type (2019-2024) & (K Doses)
Table 87. Asia-Pacific Travelers Vaccines Sales Quantity by Type (2025-2030) & (K Doses)
Table 88. Asia-Pacific Travelers Vaccines Sales Quantity by End Users (2019-2024) & (K Doses)
Table 89. Asia-Pacific Travelers Vaccines Sales Quantity by End Users (2025-2030) & (K Doses)
Table 90. Asia-Pacific Travelers Vaccines Sales Quantity by Region (2019-2024) & (K Doses)
Table 91. Asia-Pacific Travelers Vaccines Sales Quantity by Region (2025-2030) & (K Doses)
Table 92. Asia-Pacific Travelers Vaccines Consumption Value by Region (2019-2024) & (USD Million)
Table 93. Asia-Pacific Travelers Vaccines Consumption Value by Region (2025-2030) & (USD Million)
Table 94. South America Travelers Vaccines Sales Quantity by Type (2019-2024) & (K Doses)
Table 95. South America Travelers Vaccines Sales Quantity by Type (2025-2030) & (K Doses)
Table 96. South America Travelers Vaccines Sales Quantity by End Users (2019-2024) & (K Doses)
Table 97. South America Travelers Vaccines Sales Quantity by End Users (2025-2030) & (K Doses)
Table 98. South America Travelers Vaccines Sales Quantity by Country (2019-2024) & (K Doses)
Table 99. South America Travelers Vaccines Sales Quantity by Country (2025-2030) & (K Doses)
Table 100. South America Travelers Vaccines Consumption Value by Country (2019-2024) & (USD Million)
Table 101. South America Travelers Vaccines Consumption Value by Country (2025-2030) & (USD Million)
Table 102. Middle East & Africa Travelers Vaccines Sales Quantity by Type (2019-2024) & (K Doses)
Table 103. Middle East & Africa Travelers Vaccines Sales Quantity by Type (2025-2030) & (K Doses)
Table 104. Middle East & Africa Travelers Vaccines Sales Quantity by End Users (2019-2024) & (K Doses)
Table 105. Middle East & Africa Travelers Vaccines Sales Quantity by End Users (2025-2030) & (K Doses)
Table 106. Middle East & Africa Travelers Vaccines Sales Quantity by Region (2019-2024) & (K Doses)
Table 107. Middle East & Africa Travelers Vaccines Sales Quantity by Region (2025-2030) & (K Doses)
Table 108. Middle East & Africa Travelers Vaccines Consumption Value by Region (2019-2024) & (USD Million)
Table 109. Middle East & Africa Travelers Vaccines Consumption Value by Region (2025-2030) & (USD Million)
Table 110. Travelers Vaccines Raw Material
Table 111. Key Manufacturers of Travelers Vaccines Raw Materials
Table 112. Travelers Vaccines Typical Distributors
Table 113. Travelers Vaccines Typical Customers
List of Figures
Figure 1. Travelers Vaccines Picture
Figure 2. Global Travelers Vaccines Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Travelers Vaccines Consumption Value Market Share by Type in 2023
Figure 4. Meningococcal Vaccine Examples
Figure 5. Japanese Encephalitis Vaccine Examples
Figure 6. Yellow Fever Vaccine Examples
Figure 7. Hepatitis Vaccine Examples
Figure 8. Cholera Vaccine Examples
Figure 9. Other Examples
Figure 10. Global Travelers Vaccines Consumption Value by End Users, (USD Million), 2019 & 2023 & 2030
Figure 11. Global Travelers Vaccines Consumption Value Market Share by End Users in 2023
Figure 12. Tourists Examples
Figure 13. Students Examples
Figure 14. Workers Examples
Figure 15. Others Examples
Figure 16. Global Travelers Vaccines Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 17. Global Travelers Vaccines Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 18. Global Travelers Vaccines Sales Quantity (2019-2030) & (K Doses)
Figure 19. Global Travelers Vaccines Average Price (2019-2030) & (USD/Dose)
Figure 20. Global Travelers Vaccines Sales Quantity Market Share by Manufacturer in 2023
Figure 21. Global Travelers Vaccines Consumption Value Market Share by Manufacturer in 2023
Figure 22. Producer Shipments of Travelers Vaccines by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 23. Top 3 Travelers Vaccines Manufacturer (Consumption Value) Market Share in 2023
Figure 24. Top 6 Travelers Vaccines Manufacturer (Consumption Value) Market Share in 2023
Figure 25. Global Travelers Vaccines Sales Quantity Market Share by Region (2019-2030)
Figure 26. Global Travelers Vaccines Consumption Value Market Share by Region (2019-2030)
Figure 27. North America Travelers Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 28. Europe Travelers Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 29. Asia-Pacific Travelers Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 30. South America Travelers Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 31. Middle East & Africa Travelers Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 32. Global Travelers Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 33. Global Travelers Vaccines Consumption Value Market Share by Type (2019-2030)
Figure 34. Global Travelers Vaccines Average Price by Type (2019-2030) & (USD/Dose)
Figure 35. Global Travelers Vaccines Sales Quantity Market Share by End Users (2019-2030)
Figure 36. Global Travelers Vaccines Consumption Value Market Share by End Users (2019-2030)
Figure 37. Global Travelers Vaccines Average Price by End Users (2019-2030) & (USD/Dose)
Figure 38. North America Travelers Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 39. North America Travelers Vaccines Sales Quantity Market Share by End Users (2019-2030)
Figure 40. North America Travelers Vaccines Sales Quantity Market Share by Country (2019-2030)
Figure 41. North America Travelers Vaccines Consumption Value Market Share by Country (2019-2030)
Figure 42. United States Travelers Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 43. Canada Travelers Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 44. Mexico Travelers Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 45. Europe Travelers Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 46. Europe Travelers Vaccines Sales Quantity Market Share by End Users (2019-2030)
Figure 47. Europe Travelers Vaccines Sales Quantity Market Share by Country (2019-2030)
Figure 48. Europe Travelers Vaccines Consumption Value Market Share by Country (2019-2030)
Figure 49. Germany Travelers Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. France Travelers Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 51. United Kingdom Travelers Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 52. Russia Travelers Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 53. Italy Travelers Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 54. Asia-Pacific Travelers Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 55. Asia-Pacific Travelers Vaccines Sales Quantity Market Share by End Users (2019-2030)
Figure 56. Asia-Pacific Travelers Vaccines Sales Quantity Market Share by Region (2019-2030)
Figure 57. Asia-Pacific Travelers Vaccines Consumption Value Market Share by Region (2019-2030)
Figure 58. China Travelers Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. Japan Travelers Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. Korea Travelers Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 61. India Travelers Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 62. Southeast Asia Travelers Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 63. Australia Travelers Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 64. South America Travelers Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 65. South America Travelers Vaccines Sales Quantity Market Share by End Users (2019-2030)
Figure 66. South America Travelers Vaccines Sales Quantity Market Share by Country (2019-2030)
Figure 67. South America Travelers Vaccines Consumption Value Market Share by Country (2019-2030)
Figure 68. Brazil Travelers Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 69. Argentina Travelers Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 70. Middle East & Africa Travelers Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 71. Middle East & Africa Travelers Vaccines Sales Quantity Market Share by End Users (2019-2030)
Figure 72. Middle East & Africa Travelers Vaccines Sales Quantity Market Share by Region (2019-2030)
Figure 73. Middle East & Africa Travelers Vaccines Consumption Value Market Share by Region (2019-2030)
Figure 74. Turkey Travelers Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 75. Egypt Travelers Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 76. Saudi Arabia Travelers Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 77. South Africa Travelers Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 78. Travelers Vaccines Market Drivers
Figure 79. Travelers Vaccines Market Restraints
Figure 80. Travelers Vaccines Market Trends
Figure 81. Porters Five Forces Analysis
Figure 82. Manufacturing Cost Structure Analysis of Travelers Vaccines in 2023
Figure 83. Manufacturing Process Analysis of Travelers Vaccines
Figure 84. Travelers Vaccines Industrial Chain
Figure 85. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 86. Direct Channel Pros & Cons
Figure 87. Indirect Channel Pros & Cons
Figure 88. Methodology
Figure 89. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

GlaxoSmithKline
Sanofi Pasteur
Merck
Pfizer
CNBG
Sanofi Pasteur MSD
Serum Institute of India
Biokangtai
btl

Related Reports

shop_t

Purchase Options

jiaGou

Add To Cart

jiaGou

Buy Now

masterCard
visa
jcb
americanExpress
shop_b
Global Travelers Vaccines Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Travelers Vaccines Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Page: 92

Published Date: 02 Jan 2024

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description

arrow-d3
btl

Description

According to our (Global Info Research) latest study, the global Travelers Vaccines market size was valued at USD 3460.7 million in 2023 and is forecast to a readjusted size of USD 6095 million by 2030 with a CAGR of 8.4% during review period.

A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as foreign, destroy it, and "remember" it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.

Travelers are at increased risk for several infections, including familiar infections such as measles that are widely distributed but more common in developing countries. Travelers Vaccines can markedly decrease the risk for many of these infections and are an important part of pretravel preparation.

In this report, the travelers vaccines mainly covers vaccine for hepatitis A, hepatitis B, rabies, typhoid fever, yellow fever, Japanese encephalitis, meningococcal meningitis, cholera, etc.

Merck, GlaxoSmithKline and Sanofi Pasteur are the main manufacturers in the vaccine market, with a market share of more than 60% and a high degree of market concentration. North America and Europe are the main production regions, with market share of more than 40% and 30%.

The Global Info Research report includes an overview of the development of the Travelers Vaccines industry chain, the market status of Tourists (Meningococcal Vaccine, Japanese Encephalitis Vaccine), Students (Meningococcal Vaccine, Japanese Encephalitis Vaccine), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Travelers Vaccines.

Regionally, the report analyzes the Travelers Vaccines markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Travelers Vaccines market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Travelers Vaccines market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Travelers Vaccines industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Doses), revenue generated, and market share of different by Type (e.g., Meningococcal Vaccine, Japanese Encephalitis Vaccine).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Travelers Vaccines market.

Regional Analysis: The report involves examining the Travelers Vaccines market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Travelers Vaccines market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Travelers Vaccines:
Company Analysis: Report covers individual Travelers Vaccines manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Travelers Vaccines This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by End Users (Tourists, Students).

Technology Analysis: Report covers specific technologies relevant to Travelers Vaccines. It assesses the current state, advancements, and potential future developments in Travelers Vaccines areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Travelers Vaccines market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Travelers Vaccines market is split by Type and by End Users. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by End Users in terms of volume and value.

Market segment by Type
Meningococcal Vaccine
Japanese Encephalitis Vaccine
Yellow Fever Vaccine
Hepatitis Vaccine
Cholera Vaccine
Other

Market segment by End Users
Tourists
Students
Workers
Others

Major players covered
GlaxoSmithKline
Sanofi Pasteur
Merck
Pfizer
CNBG
Sanofi Pasteur MSD
Serum Institute of India
Biokangtai

Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Travelers Vaccines product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Travelers Vaccines, with price, sales, revenue and global market share of Travelers Vaccines from 2019 to 2024.
Chapter 3, the Travelers Vaccines competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Travelers Vaccines breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and end users, with sales market share and growth rate by type, end users, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Travelers Vaccines market forecast, by regions, type and end users, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Travelers Vaccines.
Chapter 14 and 15, to describe Travelers Vaccines sales channel, distributors, customers, research findings and conclusion.
btl

Table of Contents

1 Market Overview
1.1 Product Overview and Scope of Travelers Vaccines
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Travelers Vaccines Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Meningococcal Vaccine
1.3.3 Japanese Encephalitis Vaccine
1.3.4 Yellow Fever Vaccine
1.3.5 Hepatitis Vaccine
1.3.6 Cholera Vaccine
1.3.7 Other
1.4 Market Analysis by End Users
1.4.1 Overview: Global Travelers Vaccines Consumption Value by End Users: 2019 Versus 2023 Versus 2030
1.4.2 Tourists
1.4.3 Students
1.4.4 Workers
1.4.5 Others
1.5 Global Travelers Vaccines Market Size & Forecast
1.5.1 Global Travelers Vaccines Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Travelers Vaccines Sales Quantity (2019-2030)
1.5.3 Global Travelers Vaccines Average Price (2019-2030)

2 Manufacturers Profiles
2.1 GlaxoSmithKline
2.1.1 GlaxoSmithKline Details
2.1.2 GlaxoSmithKline Major Business
2.1.3 GlaxoSmithKline Travelers Vaccines Product and Services
2.1.4 GlaxoSmithKline Travelers Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 GlaxoSmithKline Recent Developments/Updates
2.2 Sanofi Pasteur
2.2.1 Sanofi Pasteur Details
2.2.2 Sanofi Pasteur Major Business
2.2.3 Sanofi Pasteur Travelers Vaccines Product and Services
2.2.4 Sanofi Pasteur Travelers Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Sanofi Pasteur Recent Developments/Updates
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business
2.3.3 Merck Travelers Vaccines Product and Services
2.3.4 Merck Travelers Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Merck Recent Developments/Updates
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business
2.4.3 Pfizer Travelers Vaccines Product and Services
2.4.4 Pfizer Travelers Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Pfizer Recent Developments/Updates
2.5 CNBG
2.5.1 CNBG Details
2.5.2 CNBG Major Business
2.5.3 CNBG Travelers Vaccines Product and Services
2.5.4 CNBG Travelers Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 CNBG Recent Developments/Updates
2.6 Sanofi Pasteur MSD
2.6.1 Sanofi Pasteur MSD Details
2.6.2 Sanofi Pasteur MSD Major Business
2.6.3 Sanofi Pasteur MSD Travelers Vaccines Product and Services
2.6.4 Sanofi Pasteur MSD Travelers Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Sanofi Pasteur MSD Recent Developments/Updates
2.7 Serum Institute of India
2.7.1 Serum Institute of India Details
2.7.2 Serum Institute of India Major Business
2.7.3 Serum Institute of India Travelers Vaccines Product and Services
2.7.4 Serum Institute of India Travelers Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Serum Institute of India Recent Developments/Updates
2.8 Biokangtai
2.8.1 Biokangtai Details
2.8.2 Biokangtai Major Business
2.8.3 Biokangtai Travelers Vaccines Product and Services
2.8.4 Biokangtai Travelers Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Biokangtai Recent Developments/Updates

3 Competitive Environment: Travelers Vaccines by Manufacturer
3.1 Global Travelers Vaccines Sales Quantity by Manufacturer (2019-2024)
3.2 Global Travelers Vaccines Revenue by Manufacturer (2019-2024)
3.3 Global Travelers Vaccines Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Travelers Vaccines by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Travelers Vaccines Manufacturer Market Share in 2023
3.4.2 Top 6 Travelers Vaccines Manufacturer Market Share in 2023
3.5 Travelers Vaccines Market: Overall Company Footprint Analysis
3.5.1 Travelers Vaccines Market: Region Footprint
3.5.2 Travelers Vaccines Market: Company Product Type Footprint
3.5.3 Travelers Vaccines Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
4.1 Global Travelers Vaccines Market Size by Region
4.1.1 Global Travelers Vaccines Sales Quantity by Region (2019-2030)
4.1.2 Global Travelers Vaccines Consumption Value by Region (2019-2030)
4.1.3 Global Travelers Vaccines Average Price by Region (2019-2030)
4.2 North America Travelers Vaccines Consumption Value (2019-2030)
4.3 Europe Travelers Vaccines Consumption Value (2019-2030)
4.4 Asia-Pacific Travelers Vaccines Consumption Value (2019-2030)
4.5 South America Travelers Vaccines Consumption Value (2019-2030)
4.6 Middle East and Africa Travelers Vaccines Consumption Value (2019-2030)

5 Market Segment by Type
5.1 Global Travelers Vaccines Sales Quantity by Type (2019-2030)
5.2 Global Travelers Vaccines Consumption Value by Type (2019-2030)
5.3 Global Travelers Vaccines Average Price by Type (2019-2030)

6 Market Segment by End Users
6.1 Global Travelers Vaccines Sales Quantity by End Users (2019-2030)
6.2 Global Travelers Vaccines Consumption Value by End Users (2019-2030)
6.3 Global Travelers Vaccines Average Price by End Users (2019-2030)

7 North America
7.1 North America Travelers Vaccines Sales Quantity by Type (2019-2030)
7.2 North America Travelers Vaccines Sales Quantity by End Users (2019-2030)
7.3 North America Travelers Vaccines Market Size by Country
7.3.1 North America Travelers Vaccines Sales Quantity by Country (2019-2030)
7.3.2 North America Travelers Vaccines Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe
8.1 Europe Travelers Vaccines Sales Quantity by Type (2019-2030)
8.2 Europe Travelers Vaccines Sales Quantity by End Users (2019-2030)
8.3 Europe Travelers Vaccines Market Size by Country
8.3.1 Europe Travelers Vaccines Sales Quantity by Country (2019-2030)
8.3.2 Europe Travelers Vaccines Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific
9.1 Asia-Pacific Travelers Vaccines Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Travelers Vaccines Sales Quantity by End Users (2019-2030)
9.3 Asia-Pacific Travelers Vaccines Market Size by Region
9.3.1 Asia-Pacific Travelers Vaccines Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Travelers Vaccines Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America
10.1 South America Travelers Vaccines Sales Quantity by Type (2019-2030)
10.2 South America Travelers Vaccines Sales Quantity by End Users (2019-2030)
10.3 South America Travelers Vaccines Market Size by Country
10.3.1 South America Travelers Vaccines Sales Quantity by Country (2019-2030)
10.3.2 South America Travelers Vaccines Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa
11.1 Middle East & Africa Travelers Vaccines Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Travelers Vaccines Sales Quantity by End Users (2019-2030)
11.3 Middle East & Africa Travelers Vaccines Market Size by Country
11.3.1 Middle East & Africa Travelers Vaccines Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Travelers Vaccines Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics
12.1 Travelers Vaccines Market Drivers
12.2 Travelers Vaccines Market Restraints
12.3 Travelers Vaccines Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain
13.1 Raw Material of Travelers Vaccines and Key Manufacturers
13.2 Manufacturing Costs Percentage of Travelers Vaccines
13.3 Travelers Vaccines Production Process
13.4 Travelers Vaccines Industrial Chain

14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Travelers Vaccines Typical Distributors
14.3 Travelers Vaccines Typical Customers

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. Global Travelers Vaccines Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Travelers Vaccines Consumption Value by End Users, (USD Million), 2019 & 2023 & 2030
Table 3. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 4. GlaxoSmithKline Major Business
Table 5. GlaxoSmithKline Travelers Vaccines Product and Services
Table 6. GlaxoSmithKline Travelers Vaccines Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. GlaxoSmithKline Recent Developments/Updates
Table 8. Sanofi Pasteur Basic Information, Manufacturing Base and Competitors
Table 9. Sanofi Pasteur Major Business
Table 10. Sanofi Pasteur Travelers Vaccines Product and Services
Table 11. Sanofi Pasteur Travelers Vaccines Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Sanofi Pasteur Recent Developments/Updates
Table 13. Merck Basic Information, Manufacturing Base and Competitors
Table 14. Merck Major Business
Table 15. Merck Travelers Vaccines Product and Services
Table 16. Merck Travelers Vaccines Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Merck Recent Developments/Updates
Table 18. Pfizer Basic Information, Manufacturing Base and Competitors
Table 19. Pfizer Major Business
Table 20. Pfizer Travelers Vaccines Product and Services
Table 21. Pfizer Travelers Vaccines Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Pfizer Recent Developments/Updates
Table 23. CNBG Basic Information, Manufacturing Base and Competitors
Table 24. CNBG Major Business
Table 25. CNBG Travelers Vaccines Product and Services
Table 26. CNBG Travelers Vaccines Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. CNBG Recent Developments/Updates
Table 28. Sanofi Pasteur MSD Basic Information, Manufacturing Base and Competitors
Table 29. Sanofi Pasteur MSD Major Business
Table 30. Sanofi Pasteur MSD Travelers Vaccines Product and Services
Table 31. Sanofi Pasteur MSD Travelers Vaccines Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Sanofi Pasteur MSD Recent Developments/Updates
Table 33. Serum Institute of India Basic Information, Manufacturing Base and Competitors
Table 34. Serum Institute of India Major Business
Table 35. Serum Institute of India Travelers Vaccines Product and Services
Table 36. Serum Institute of India Travelers Vaccines Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Serum Institute of India Recent Developments/Updates
Table 38. Biokangtai Basic Information, Manufacturing Base and Competitors
Table 39. Biokangtai Major Business
Table 40. Biokangtai Travelers Vaccines Product and Services
Table 41. Biokangtai Travelers Vaccines Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Biokangtai Recent Developments/Updates
Table 43. Global Travelers Vaccines Sales Quantity by Manufacturer (2019-2024) & (K Doses)
Table 44. Global Travelers Vaccines Revenue by Manufacturer (2019-2024) & (USD Million)
Table 45. Global Travelers Vaccines Average Price by Manufacturer (2019-2024) & (USD/Dose)
Table 46. Market Position of Manufacturers in Travelers Vaccines, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 47. Head Office and Travelers Vaccines Production Site of Key Manufacturer
Table 48. Travelers Vaccines Market: Company Product Type Footprint
Table 49. Travelers Vaccines Market: Company Product Application Footprint
Table 50. Travelers Vaccines New Market Entrants and Barriers to Market Entry
Table 51. Travelers Vaccines Mergers, Acquisition, Agreements, and Collaborations
Table 52. Global Travelers Vaccines Sales Quantity by Region (2019-2024) & (K Doses)
Table 53. Global Travelers Vaccines Sales Quantity by Region (2025-2030) & (K Doses)
Table 54. Global Travelers Vaccines Consumption Value by Region (2019-2024) & (USD Million)
Table 55. Global Travelers Vaccines Consumption Value by Region (2025-2030) & (USD Million)
Table 56. Global Travelers Vaccines Average Price by Region (2019-2024) & (USD/Dose)
Table 57. Global Travelers Vaccines Average Price by Region (2025-2030) & (USD/Dose)
Table 58. Global Travelers Vaccines Sales Quantity by Type (2019-2024) & (K Doses)
Table 59. Global Travelers Vaccines Sales Quantity by Type (2025-2030) & (K Doses)
Table 60. Global Travelers Vaccines Consumption Value by Type (2019-2024) & (USD Million)
Table 61. Global Travelers Vaccines Consumption Value by Type (2025-2030) & (USD Million)
Table 62. Global Travelers Vaccines Average Price by Type (2019-2024) & (USD/Dose)
Table 63. Global Travelers Vaccines Average Price by Type (2025-2030) & (USD/Dose)
Table 64. Global Travelers Vaccines Sales Quantity by End Users (2019-2024) & (K Doses)
Table 65. Global Travelers Vaccines Sales Quantity by End Users (2025-2030) & (K Doses)
Table 66. Global Travelers Vaccines Consumption Value by End Users (2019-2024) & (USD Million)
Table 67. Global Travelers Vaccines Consumption Value by End Users (2025-2030) & (USD Million)
Table 68. Global Travelers Vaccines Average Price by End Users (2019-2024) & (USD/Dose)
Table 69. Global Travelers Vaccines Average Price by End Users (2025-2030) & (USD/Dose)
Table 70. North America Travelers Vaccines Sales Quantity by Type (2019-2024) & (K Doses)
Table 71. North America Travelers Vaccines Sales Quantity by Type (2025-2030) & (K Doses)
Table 72. North America Travelers Vaccines Sales Quantity by End Users (2019-2024) & (K Doses)
Table 73. North America Travelers Vaccines Sales Quantity by End Users (2025-2030) & (K Doses)
Table 74. North America Travelers Vaccines Sales Quantity by Country (2019-2024) & (K Doses)
Table 75. North America Travelers Vaccines Sales Quantity by Country (2025-2030) & (K Doses)
Table 76. North America Travelers Vaccines Consumption Value by Country (2019-2024) & (USD Million)
Table 77. North America Travelers Vaccines Consumption Value by Country (2025-2030) & (USD Million)
Table 78. Europe Travelers Vaccines Sales Quantity by Type (2019-2024) & (K Doses)
Table 79. Europe Travelers Vaccines Sales Quantity by Type (2025-2030) & (K Doses)
Table 80. Europe Travelers Vaccines Sales Quantity by End Users (2019-2024) & (K Doses)
Table 81. Europe Travelers Vaccines Sales Quantity by End Users (2025-2030) & (K Doses)
Table 82. Europe Travelers Vaccines Sales Quantity by Country (2019-2024) & (K Doses)
Table 83. Europe Travelers Vaccines Sales Quantity by Country (2025-2030) & (K Doses)
Table 84. Europe Travelers Vaccines Consumption Value by Country (2019-2024) & (USD Million)
Table 85. Europe Travelers Vaccines Consumption Value by Country (2025-2030) & (USD Million)
Table 86. Asia-Pacific Travelers Vaccines Sales Quantity by Type (2019-2024) & (K Doses)
Table 87. Asia-Pacific Travelers Vaccines Sales Quantity by Type (2025-2030) & (K Doses)
Table 88. Asia-Pacific Travelers Vaccines Sales Quantity by End Users (2019-2024) & (K Doses)
Table 89. Asia-Pacific Travelers Vaccines Sales Quantity by End Users (2025-2030) & (K Doses)
Table 90. Asia-Pacific Travelers Vaccines Sales Quantity by Region (2019-2024) & (K Doses)
Table 91. Asia-Pacific Travelers Vaccines Sales Quantity by Region (2025-2030) & (K Doses)
Table 92. Asia-Pacific Travelers Vaccines Consumption Value by Region (2019-2024) & (USD Million)
Table 93. Asia-Pacific Travelers Vaccines Consumption Value by Region (2025-2030) & (USD Million)
Table 94. South America Travelers Vaccines Sales Quantity by Type (2019-2024) & (K Doses)
Table 95. South America Travelers Vaccines Sales Quantity by Type (2025-2030) & (K Doses)
Table 96. South America Travelers Vaccines Sales Quantity by End Users (2019-2024) & (K Doses)
Table 97. South America Travelers Vaccines Sales Quantity by End Users (2025-2030) & (K Doses)
Table 98. South America Travelers Vaccines Sales Quantity by Country (2019-2024) & (K Doses)
Table 99. South America Travelers Vaccines Sales Quantity by Country (2025-2030) & (K Doses)
Table 100. South America Travelers Vaccines Consumption Value by Country (2019-2024) & (USD Million)
Table 101. South America Travelers Vaccines Consumption Value by Country (2025-2030) & (USD Million)
Table 102. Middle East & Africa Travelers Vaccines Sales Quantity by Type (2019-2024) & (K Doses)
Table 103. Middle East & Africa Travelers Vaccines Sales Quantity by Type (2025-2030) & (K Doses)
Table 104. Middle East & Africa Travelers Vaccines Sales Quantity by End Users (2019-2024) & (K Doses)
Table 105. Middle East & Africa Travelers Vaccines Sales Quantity by End Users (2025-2030) & (K Doses)
Table 106. Middle East & Africa Travelers Vaccines Sales Quantity by Region (2019-2024) & (K Doses)
Table 107. Middle East & Africa Travelers Vaccines Sales Quantity by Region (2025-2030) & (K Doses)
Table 108. Middle East & Africa Travelers Vaccines Consumption Value by Region (2019-2024) & (USD Million)
Table 109. Middle East & Africa Travelers Vaccines Consumption Value by Region (2025-2030) & (USD Million)
Table 110. Travelers Vaccines Raw Material
Table 111. Key Manufacturers of Travelers Vaccines Raw Materials
Table 112. Travelers Vaccines Typical Distributors
Table 113. Travelers Vaccines Typical Customers
List of Figures
Figure 1. Travelers Vaccines Picture
Figure 2. Global Travelers Vaccines Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Travelers Vaccines Consumption Value Market Share by Type in 2023
Figure 4. Meningococcal Vaccine Examples
Figure 5. Japanese Encephalitis Vaccine Examples
Figure 6. Yellow Fever Vaccine Examples
Figure 7. Hepatitis Vaccine Examples
Figure 8. Cholera Vaccine Examples
Figure 9. Other Examples
Figure 10. Global Travelers Vaccines Consumption Value by End Users, (USD Million), 2019 & 2023 & 2030
Figure 11. Global Travelers Vaccines Consumption Value Market Share by End Users in 2023
Figure 12. Tourists Examples
Figure 13. Students Examples
Figure 14. Workers Examples
Figure 15. Others Examples
Figure 16. Global Travelers Vaccines Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 17. Global Travelers Vaccines Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 18. Global Travelers Vaccines Sales Quantity (2019-2030) & (K Doses)
Figure 19. Global Travelers Vaccines Average Price (2019-2030) & (USD/Dose)
Figure 20. Global Travelers Vaccines Sales Quantity Market Share by Manufacturer in 2023
Figure 21. Global Travelers Vaccines Consumption Value Market Share by Manufacturer in 2023
Figure 22. Producer Shipments of Travelers Vaccines by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 23. Top 3 Travelers Vaccines Manufacturer (Consumption Value) Market Share in 2023
Figure 24. Top 6 Travelers Vaccines Manufacturer (Consumption Value) Market Share in 2023
Figure 25. Global Travelers Vaccines Sales Quantity Market Share by Region (2019-2030)
Figure 26. Global Travelers Vaccines Consumption Value Market Share by Region (2019-2030)
Figure 27. North America Travelers Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 28. Europe Travelers Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 29. Asia-Pacific Travelers Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 30. South America Travelers Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 31. Middle East & Africa Travelers Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 32. Global Travelers Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 33. Global Travelers Vaccines Consumption Value Market Share by Type (2019-2030)
Figure 34. Global Travelers Vaccines Average Price by Type (2019-2030) & (USD/Dose)
Figure 35. Global Travelers Vaccines Sales Quantity Market Share by End Users (2019-2030)
Figure 36. Global Travelers Vaccines Consumption Value Market Share by End Users (2019-2030)
Figure 37. Global Travelers Vaccines Average Price by End Users (2019-2030) & (USD/Dose)
Figure 38. North America Travelers Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 39. North America Travelers Vaccines Sales Quantity Market Share by End Users (2019-2030)
Figure 40. North America Travelers Vaccines Sales Quantity Market Share by Country (2019-2030)
Figure 41. North America Travelers Vaccines Consumption Value Market Share by Country (2019-2030)
Figure 42. United States Travelers Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 43. Canada Travelers Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 44. Mexico Travelers Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 45. Europe Travelers Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 46. Europe Travelers Vaccines Sales Quantity Market Share by End Users (2019-2030)
Figure 47. Europe Travelers Vaccines Sales Quantity Market Share by Country (2019-2030)
Figure 48. Europe Travelers Vaccines Consumption Value Market Share by Country (2019-2030)
Figure 49. Germany Travelers Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. France Travelers Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 51. United Kingdom Travelers Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 52. Russia Travelers Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 53. Italy Travelers Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 54. Asia-Pacific Travelers Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 55. Asia-Pacific Travelers Vaccines Sales Quantity Market Share by End Users (2019-2030)
Figure 56. Asia-Pacific Travelers Vaccines Sales Quantity Market Share by Region (2019-2030)
Figure 57. Asia-Pacific Travelers Vaccines Consumption Value Market Share by Region (2019-2030)
Figure 58. China Travelers Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. Japan Travelers Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. Korea Travelers Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 61. India Travelers Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 62. Southeast Asia Travelers Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 63. Australia Travelers Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 64. South America Travelers Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 65. South America Travelers Vaccines Sales Quantity Market Share by End Users (2019-2030)
Figure 66. South America Travelers Vaccines Sales Quantity Market Share by Country (2019-2030)
Figure 67. South America Travelers Vaccines Consumption Value Market Share by Country (2019-2030)
Figure 68. Brazil Travelers Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 69. Argentina Travelers Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 70. Middle East & Africa Travelers Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 71. Middle East & Africa Travelers Vaccines Sales Quantity Market Share by End Users (2019-2030)
Figure 72. Middle East & Africa Travelers Vaccines Sales Quantity Market Share by Region (2019-2030)
Figure 73. Middle East & Africa Travelers Vaccines Consumption Value Market Share by Region (2019-2030)
Figure 74. Turkey Travelers Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 75. Egypt Travelers Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 76. Saudi Arabia Travelers Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 77. South Africa Travelers Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 78. Travelers Vaccines Market Drivers
Figure 79. Travelers Vaccines Market Restraints
Figure 80. Travelers Vaccines Market Trends
Figure 81. Porters Five Forces Analysis
Figure 82. Manufacturing Cost Structure Analysis of Travelers Vaccines in 2023
Figure 83. Manufacturing Process Analysis of Travelers Vaccines
Figure 84. Travelers Vaccines Industrial Chain
Figure 85. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 86. Direct Channel Pros & Cons
Figure 87. Indirect Channel Pros & Cons
Figure 88. Methodology
Figure 89. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Discussion of all the project requirements and queries

Validation and triangulation of secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

GlaxoSmithKline
Sanofi Pasteur
Merck
Pfizer
CNBG
Sanofi Pasteur MSD
Serum Institute of India
Biokangtai
btl

Related Reports

jiaGou

Add To Cart

gouMai

Buy Now